NDAINJECTIONINJECTABLE
Approved
May 1998
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
OPTIRAY 240 (ioversol) by Guerbet is x-ray contrast activity [moa]. First approved in 1998.
Drug data last refreshed 22h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
OPTIRAY 240 (ioversol) is an iodinated radiographic contrast agent administered by injection to enhance visualization of internal body structures during X-ray imaging procedures. It works through X-ray contrast activity, allowing radiologists to obtain clearer diagnostic images of blood vessels, organs, and tissues. The drug is indicated for use in various diagnostic imaging modalities where contrast enhancement is required.
LOE Approaching
Product is in late-stage lifecycle with LOE approaching, suggesting cost-optimization and efficiency-focused team operations rather than growth investments.
Mechanism of Action
X-Ray Contrast Activity
Pharmacologic Class:
Radiographic Contrast Agent
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on OPTIRAY 240 offers experience in managing mature pharmaceutical products through late lifecycle and LOE transition phases. This role develops expertise in cost management, market defense, and operational efficiency—valuable skills for brand management in challenging market environments.
Product ManagerSales Representative
Worked on OPTIRAY 240 at Guerbet? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.